Geneact Biotech Private Limited
About Geneact Biotech Private Limited
Data last updated:
Geneact Biotech Private Limited is a private limited company based in Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 27 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2012PTC245360. Its GSTIN is 07AAECG9851E2ZG (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Alok Kumar and Poonam Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 307 Aggarwal Tower C U Block Pitam Pura, Delhi, India – 110088.
As per the financials filed for FY 2022, the company reported a revenue of ₹9.39 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹2,490 (net margin 0.3%) and EBITDA of ₹3,690 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 56% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Geneact Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address307 Aggarwal Tower C U Block Pitam Pura, Delhi, India – 110088
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Geneact Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Geneact Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Geneact Biotech Private Limited, buy the company report.
Financials of Geneact Biotech Private Limited
FY 2022 filings availableGeneact Biotech Private Limited reported revenue of ₹9.39 Lakh (down 4% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 56% over three years, including a 4% fall in the latest year. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,690 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,490 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Geneact Biotech Private Limited, buy the company report.
Board of directors of Geneact Biotech Private Limited
Geneact Biotech has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Kumar Also directs: Oscar Diagnostic Services Private Limited | Additional Director | 04 Feb 2015 | 11 Years 8 Months | Current |
| Alok Kumar Also directs: Oscar Diagnostic Services Private Limited | Director | 28 Sep 2013 | 13 Years 0 Months | Current |
Peer comparison
Geneact Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chlore Aqua Chemicals Private Limited | ₹9.39 Lakh (FY 2022) | -82.0% | Delhi, India | |||
| Pankhi Sales Private Limited | ₹9.39 Lakh (FY 2024) | 400.0% | Lucknow, Uttar Pradesh, India | |||
| Skysine Export Import Private Limited | ₹9.39 Lakh (FY 2023) | -87.0% | Indrapuram, Uttar Pradesh, India | |||
| Prabhi Services Private Limited | ₹9.39 Lakh (FY 2024) | Delhi, India | ||||
| Bajwa Food Exports Private Limited | ₹9.39 Lakh (FY 2021) | Chandigarh, India | ||||
| Geneact Biotech Private Limitedthis company | ₹9.39 Lakh (FY 2022) | ₹2,490 | 0.3% | -4.0% | Delhi, India | |
| Verein Pharmaceuticals Private Limited | ₹9.39 Lakh (FY 2021) | -56.0% | New Delhi, Delhi, India | |||
| Vetmax Pharmaceuticals Private Limited | ₹9.39 Lakh (FY 2025) | -49.0% | Uttar Pradesh, India | |||
| Vatvriksh Consumer Care Private Limited | ₹9.38 Lakh (FY 2021) | 38.0% | Lucknow, Uttar Pradesh, India | |||
| Shri Bankey Bihari Assaying and Hallmark Centre Private Limited | ₹9.38 Lakh (FY 2025) | 10.0% | Bareilly, Uttar Pradesh, India | |||
| Proficio Life Sciences Private Limited | ₹9.38 Lakh (FY 2021) | -49.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Geneact Biotech Private Limited, buy the company report.
Auditor
Geneact Biotech Private Limited is audited by I P ARORA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| I P ARORA & ASSOCIATES | FY 2017 | 025034N |
Shareholding
The shareholding of Geneact Biotech Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Geneact Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Geneact Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Geneact Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Geneact Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECG9851E2ZG | Delhi | Active | 07 Sep 2017 |
To see the full GST registrations and return filing status of Geneact Biotech Private Limited, buy the company report.
Recent activity
Geneact Biotech Private Limited has 9 board changes on record since 2013: 2 appointments and 7 cessations. The latest: Ankur Gupta ceased to be Director on 31 Aug 2021.
Frequently asked questions
Geneact Biotech is an active private limited company based in Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 27 November 2012 (14+ years old) and is registered under CIN U74140DL2012PTC245360.
Geneact Biotech has 2 current directors:
- Poonam Kumar - Additional Director
- Alok Kumar - Director
The latest financial statements of Geneact Biotech on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Geneact Biotech is 07AAECG9851E2ZG, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Geneact Biotech is U74140DL2012PTC245360. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Geneact Biotech was incorporated on 27 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Geneact Biotech by revenue are Chlore Aqua Chemicals Private Limited, Pankhi Sales Private Limited, Skysine Export Import Private Limited, Prabhi Services Private Limited, Bajwa Food Exports Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ankur Gupta ceased to be Director on 31 Aug 2021. Jayakrishnan Kotteeri ceased to be Additional Director on 31 Aug 2021. Poonam Singh Kushwaha ceased to be Additional Director on 05 Feb 2015. Geneact Biotech has 9 board changes on record in total.
The registered office of Geneact Biotech is at 307 Aggarwal Tower C U Block Pitam Pura, Delhi, India – 110088.
Geneact Biotech operates in the trading industry, in the wholesale segment.
The compliance status of Geneact Biotech is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.